Utilization and Optimization of Beta-Blockers on Heart Failure Patients with Reduced Ejection Fraction (HFrEF) at Cardiac Clinic of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study

References

• Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the heart failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing committee of the universal definition of heart failure. J Card Fail. 2021;27:S1071–S9164.
   PubMed Web of Science ®Google Scholar
• Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–1380. doi:10.1056/NEJMra072139
   PubMed Web of Science ®Google Scholar
• Hill JA, Olson EN. Muscle: Fundamental Biology and Mechanisms of Disease. New York, NY: Acadamicpressl; 2012.
   Google Scholar
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contributio; 2021.
   Google Scholar
• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2
   PubMedGoogle Scholar
• Ogah OS, Adebiyi A, Sliwa K. Heart failure in Sub-Saharan Africa. In: Rescigno G, Firstenberg MS, editors. Topics in Heart Failure Management [Internet]. London: IntechOpen; 2019.
   Google Scholar
• Tsega TA, Demissei BG. A systematic review of epidemiology, treatment and prognosis of heart failure in adult in Ethiopia. J Cardiovasc Med. 2018;19(3):91–97.
   Google Scholar
• Shewaye A, Bayisa T, Adamu F, Abdissa S. Medical admissions and outcomes at Saint Paul’s Hospital, Addis Ababa, Ethiopia: a retrospective study. Ethiop J Health Dev. 2017;30:50–56.
   Web of Science ®Google Scholar
• Levy D, Kenchaiah S, Larson MG, et al. Long term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402. doi:10.1056/NEJMoa020265
   PubMed Web of Science ®Google Scholar
• World Health Organization. Noncommunicable diseases country profiles; 2018.
   Google Scholar
• Meshesha MD, HussenKabthymer R, MechaAbafogi M. Mortality and its associated factors among hospitalized heart failure patients: the case of South West Ethiopia. Cardiol Res Pract. 2021;2021:8. doi:10.1155/2021/5951040
   Web of Science ®Google Scholar
• Mulubirhan T, Nedi T, Mekonnen D, Berha AB. Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study. BMC Cardiovasc Disord. 2020;20:16. doi:10.1186/s12872-019-01318-x
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239. doi:10.1016/j.jacc.2013.05.019
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–e161. doi:10.1161/CIR.0000000000000509
   PubMed Web of Science ®Google Scholar
• Ponikowsk P, Voors AA, Anker SD, et al. ECS guidelines for heart failure treatment. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;17:e263–e421.
   Google Scholar
• Wallukat G. The beta-adrenergic receptors. Herz. 2002;27(7):683–690. doi:10.1007/s00059-002-2434-z
   PubMed Web of Science ®Google Scholar
• Florea VG, Cohn JN. The autonomic nervous system and heart failure. Circ Res. 2014;114:1815–1826. doi:10.1161/CIRCRESAHA.114.302589
   PubMed Web of Science ®Google Scholar
• Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658. doi:10.1056/NEJM200105313442201
   PubMed Web of Science ®Google Scholar
• Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–1355. doi:10.1056/NEJM199605233342101
   PubMed Web of Science ®Google Scholar
• The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001–2007. doi:10.1016/S0140-6736(99)04440-2
   PubMed Web of Science ®Google Scholar
• The CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13. doi:10.1016/S0140-6736(98)11181-9
   PubMed Web of Science ®Google Scholar
• Flather MD, Shibata MC, Coats AJS, et al; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26:215–225. doi:10.1093/eurheartj/ehi115
   PubMed Web of Science ®Google Scholar
• Böhm M, Maack C. Treatment of heart failure with beta-blockers. Mechanisms and results. Basic Res Cardiol. 2000;95:I15–I24. doi:10.1007/s003950070004
   PubMed Web of Science ®Google Scholar
• Basile JN. Titration of beta-blockers in heart failure. How to maximize benefit while minimizing adverse events. Postgrad Med. 2003;113:63–70. doi:10.3810/pgm.2003.03.1389
   PubMed Web of Science ®Google Scholar
• Wikstrand J, Hjalmarson A, Waagstein F, et al. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol. 2002;40:491–498. doi:10.1016/S0735-1097(02)01970-8
   PubMed Web of Science ®Google Scholar
• Franke J, Wolter JS, Meme L, et al. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed? Clin Res Cardiol. 2013;102:23–31. doi:10.1007/s00392-012-0489-2
   PubMed Web of Science ®Google Scholar
• Legesse Y, Asgedom S, Demoz G, Gidey K. Treatment optimization of beta-blockers in chronic heart failure therapy. Sci Rep. 2020;10:15903. doi:10.1038/s41598-020-72836-4
   PubMed Web of Science ®Google Scholar
• Berthelot E, Eicher J, Salvat M, Seronde M, de Groote P. Medical inertia in the optimization of heart failure treatment after discharge and its relationship to outcome. Health Care Curr Rev. 2018;2:12.
   Google Scholar
• de Groote P, Isnard R, Assyag P, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail. 2007;9:1205–1211. doi:10.1016/j.ejheart.2007.09.008
   PubMed Web of Science ®Google Scholar
• Loop MS, Van Dyke MK, Chen L, et al. Low utilization of beta-blockers among medicare beneficiaries hospitalized for heart failure with reduced ejection fraction. J Card Fail. 2018;16:31102–31107.
   Google Scholar
• Gheorghiade M, Albert NM, Curtis AB, et al. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012;18(1):9–17. doi:10.1111/j.1751-7133.2011.00250.x
   PubMedGoogle Scholar
• Bhatt AS, DeVore AD, DeWald TA, Swedberg K, Mentz RJ. Achieving a maximally tolerated β-blocker dose in heart failure patients: is there room for improvement? J Am Coll Cardiol. 2017;69(20):2542–2550. doi:10.1016/j.jacc.2017.03.563
   PubMed Web of Science ®Google Scholar
• Solal AC, Leurs I, Assyag P, et al. Optimization of heart failure medical treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Arch Cardiovasc Dis. 2012;105:355–365. doi:10.1016/j.acvd.2012.04.003
   PubMed Web of Science ®Google Scholar